Cationic polysaccharides for delivery of phosphoinositides to cells for therapeutic purpose

a technology of phosphoinositide and cationic polysaccharide, which is applied in the direction of pharmaceutical non-active ingredients, organic active ingredients, pharmaceutical active ingredients, etc., can solve the problems of morbidity and mortality among diabetic patients, altered skin wound healing, and limited strategy

Active Publication Date: 2019-07-16
KOST JOSEPH
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This approach enables effective internalization of phosphoinositides by cells, enhancing autophagy flux and insulin-mediated signaling, while minimizing toxicity and improving wound healing processes, thus addressing impaired phosphoinositide-mediated signaling in diseases like diabetes and cancer.

Problems solved by technology

Current pharmacological therapeutics is mostly based on activation or inhibition of enzymes or receptors, a strategy somewhat limited when the disease process involves impaired insulin signaling capacity.
Altered skin wound healing is a common cause of morbidity and mortality among diabetic patients, caused in response to a rise in blood sugar concentrations.
It has been suggested that obesity which is correlated with elevated triglycerides, free fatty acids and glucose concentrations in the plasma results in defective autophagy in the liver, which promotes elevated endoplasmic reticulum stress and impaired insulin signaling.
Although PIPs are attractive candidates for therapeutic purposes, such applications are challenged, inter alia, by the need to overcome permeability barriers through the plasma membrane, and by the poor stability of the PIPs.
However, the widely-used carriers, e.g. polyethyleneimine (PEI) suffer from toxicity, poor efficiency, and low biodegradability (Fischer, 1999, Godbey, 2001).

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cationic polysaccharides for delivery of phosphoinositides to cells for therapeutic purpose
  • Cationic polysaccharides for delivery of phosphoinositides to cells for therapeutic purpose
  • Cationic polysaccharides for delivery of phosphoinositides to cells for therapeutic purpose

Examples

Experimental program
Comparison scheme
Effect test

example 2

PI3P Complex Characterization

[0117]The hydrodynamic radius of the Q-starch / PI3P complexes without sonication and filtration of the PI3P solution prior complexation is shown in FIG. 4A for N / P ratios of 0.5 and 1. As seen in FIG. 4A, the mean hydrodynamic radius of self-assembled Q-starch / PI3P complexes, as measured by Dynamic Light Scattering (DLS), is approximately 116 nm. The zeta potentials of these complexes are shown in FIG. 4B for N / P ratios of 0.5 and 1 and for PI3P and Q-starch alone. As seen in FIG. 4B, the zeta potential increases with increasing the N / P ratio. The hydrodynamic radius of the Q-starch / PI3P complexes prepared with sonication and filtration of the PI3P solution prior complexation is shown in FIG. 5A for N / P ratios of 1 to 5. As seen in FIG. 5A, the hydrodynamic radius of self-assembled Q-starch / PI3P complexes, as measured by Dynamic Light Scattering (DLS), inversely depends on the N / P ratio (between 254.18 nm at N / P=1 and 38.19 nm at N / P=5). The zeta potentia...

example 3

Localization of Q-Starch / PI3P Complexes

[0118]Cellular uptake of Q-starch5-DTAF / PI3P complexes (DTAF-5-(4,6-Dichlorotriazinyl) Aminofluorescein, a reactive green dye) was visualized using spinning disk confocal microscope. HEK-293 cells were seeded in 6-well culture plates on coverslips and incubated over-night at 37° C. with 5% CO2. Then the cells were supplemented with 25 μL of Q-starch5-DTAF / PI3P complexes solution (all diluted to CPI3P=0.5 μM in DMEM). Afterwards the cells were incubated for 2 hours t 37° C. with 5% CO2. The cells were fixed with 4% paraformaldehyde. Cell membrane was labeled by WGA Alexa Fluor 555.

[0119]Imaging experiments using an imaging flow cytometer (Amnis ImageStreamX) were performed to quantitatively evaluate the cellular internalization of Q-starch5-DTAF / PI3P complexes. HEK-293 cells were seeded in 6-well culture plates and incubated over-night at 37° C. with 5% CO2. Then the cells were supplemented with 25 μL of Q-starch5-DTAF / PI3P complexes solution (a...

example 4

Flux

[0121]Up-regulation of autophagy in HEK293 cells with the Q-starch / PI3P complexes was assessed by comparing the autophagy flux for the following conditions (FIG. 7): flux after 3 hours of serum starvation, flux after inhibition of the formation of endogenous PI3P by 3-MA (3-Methyladenine), flux after treatment with 3-MA and complexes at N / P ratio of 2 and flux after treatment with 3-MA and PI3P. As can be seen in FIGS. 7A-7B, inhibiting endogenous PI3P formation leads to a decrease in the autophagy flux compared to serum starvation. Treatment with Q-starch / PI3P complexes at N / P=2 succeeds to up-regulate autophagy flux even when compared to serum starvation levels. Treatment with PI3P alone did not affect the levels of autophagy flux compared to treatment with 3-MA.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to View More

Abstract

The present invention provides a complex comprising at least one phosphoinositide and at least one positively charged modified polysaccharide, pharmaceutical compositions comprising the complex, methods for treatment of a disease, disorder or condition associated with impaired phosphoinositide-mediated signaling comprising administering the complex to an subject in need, and methods for delivery of a phosphoinositide into cells, comprising contacting the cells with the complex of the invention.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]This application claims the benefit of U.S. Provisional Application Ser. No. 62 / 206,921 filed Aug. 19, 2015, the disclosure of which is expressly incorporated herein by reference.FIELD OF THE INVENTION[0002]The present invention relates to the use of modified positively charged polysaccharides for the delivery of phosphoinositides to mammalian cells and the treatment of diseases, disorders or conditions associated with impaired phosphoinositide-mediated signaling.BACKGROUND OF THE INVENTION[0003]Phosphoinositides (PIPs) are a group of inter-convertible lipid messengers harboring single, double or triple phosphoryl moieties on positions 3, 4 and / or 5 of their inositol ring. Although they account for a minor fraction of total cellular lipids, PIPs appear to be major second messengers in signaling networks by tyrosine kinase receptors of hormones and growth factors, by several G-coupled receptors, as well as by environmental cellular stresse...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityPatents(United States)
IPC IPC(8): A61K31/718A61K47/61
CPCA61K47/61A61K31/718
InventorKOST, JOSEPHGOLDBART, RIKITRAITEL, TAMARMARELLY, NITZANRUDICH, ASSAFHOLLANDER, ETILI
OwnerKOST JOSEPH